Evidence map›Paper›PMID 29399163›Full record

ArticleOncology letters2018

Increased expression of the high-mannose

Krajang Talabnin, Chutima Talabnin, Mayumi Ishihara, Parastoo Azadi

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Inferring Recombination Events in SARS-CoV-2 Variants In Silico.Advances in experimental medicine and biology · 2023
    Article
  6. Article
  7. Cholangiocarcinoma.Nature reviews. Disease primers · 2021
    Review
  8. High expression of tissueThe Journal of international medical research · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.Laboratory investigation; a journal of technical methods and pathology · 2020
    Article
  13. Article
  14. Ganglioside GM2: a potential biomarker for cholangiocarcinoma.The Journal of international medical research · 2020
    Article
  15. Article
  16. Review
  17. Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Krajang TalabninSchool of Pathology, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Chutima TalabninLiver Fluke and Cholangiocarcinoma Research Center, Khon Kaen University, Khon Kaen 40002, Thailand.
Mayumi IshiharaComplex Carbohydrate Research Center, The University of Georgia, Athens, GA 30602, USA.
Parastoo AzadiComplex Carbohydrate Research Center, The University of Georgia, Athens, GA 30602, USA.
University of Georgia · USKhon Kaen University · THSuranaree University of Technology · TH

Funding

TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)P41GM103490 · NIGMS · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2012 to 2018
$13.7M
NIGMS NIH HHS P41 GM103490
6 · The paper itself

Abstract

Changes in protein glycosylation have been reported in various types of cancer, including cholangiocarcinoma (CCA). Nanospray ionization-linear ion trap mass spectrometry (NSI-MS

Indexed as

cholangiocarcinomahigh-mannose N-glycansTri-antennary N-glycans

Identifiers

PMID29399163
PMCPMC5772869
OpenAlexW2767745426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.